14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.75 $7.35 Friday, 3rd May 2024 FATE stock ended at $4.06. This is 0.98% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 11.11% from a day low at $4.05 to a day high of $4.50.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Oct 01, 2021 $59.66 $60.47 $57.22 $59.50 961 961
Sep 30, 2021 $60.13 $60.74 $58.92 $59.27 1 122 694
Sep 29, 2021 $61.66 $62.80 $58.92 $59.80 866 867
Sep 28, 2021 $62.53 $63.05 $59.92 $60.79 1 252 734
Sep 27, 2021 $64.73 $65.39 $62.35 $64.36 905 780
Sep 24, 2021 $68.30 $68.63 $64.41 $64.85 1 098 845
Sep 23, 2021 $69.79 $70.29 $67.28 $68.86 831 050
Sep 22, 2021 $68.24 $69.72 $67.67 $68.89 464 817
Sep 21, 2021 $67.68 $70.94 $67.03 $68.13 530 444
Sep 20, 2021 $68.38 $70.39 $66.90 $67.20 1 122 259
Sep 17, 2021 $67.14 $72.29 $65.60 $71.60 2 060 373
Sep 16, 2021 $66.23 $67.16 $64.67 $66.51 481 342
Sep 15, 2021 $64.63 $66.83 $64.11 $66.50 713 278
Sep 14, 2021 $66.03 $67.11 $64.09 $64.81 767 876
Sep 13, 2021 $69.51 $69.51 $65.20 $65.78 1 026 003
Sep 10, 2021 $70.11 $70.50 $67.73 $68.43 706 039
Sep 09, 2021 $69.21 $72.67 $68.62 $69.32 957 239
Sep 08, 2021 $73.00 $74.35 $69.39 $69.52 938 570
Sep 07, 2021 $73.10 $75.79 $72.63 $73.16 1 983 282
Sep 03, 2021 $75.31 $75.73 $72.11 $72.98 926 041
Sep 02, 2021 $76.10 $76.42 $74.60 $75.50 721 013
Sep 01, 2021 $73.46 $76.35 $73.46 $75.30 910 684
Aug 31, 2021 $71.81 $73.38 $71.07 $73.25 620 235
Aug 30, 2021 $73.00 $74.69 $71.62 $71.74 709 748
Aug 27, 2021 $71.64 $73.95 $71.00 $72.64 1 089 809
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT